chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired Product Used; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men B NVS (Bexsero) (batch number ABXA57AA, expiry date 30th September 2021) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd October 2021, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 3rd October 2021, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. Pharmacist reported that over the weekend a different pharmacist administered a dose of Bexsero to patient on 3rd October 2021 that was expired on 30th September 2021, which led to expired vaccine used. Health care professional gave permission to follow up The reporter consented to follow up.
Shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2014, at approximately age 61, the patient was administered the zoster vaccine live (ZOSTAVAX) by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a healthcare provider for the following injury resulting from her zoster vaccine live (ZOSTAVAX) use: Shingles. The patient claimed damages as a result of: injury to herself and economic losses. The outcome of the shingles is unknown.  Additional information has been requested.
While administering vax to pt,  the syringe disconnect and the vaccine squirted in the nurse's mouth and nostrils. At the time, she was being treated for a sinus infection with Amoxicillin. The infection  worsened within 2 days of exposure to fax and the nurse's physician increased antibiotic dosage. Physician does not correlate worsening of infection to the vax exposure.
Tiredness,  sleeping more,  headache,  muscle pain, mild chills,  feeling unwell
Patients mom reported that patient was tired, lacking energy, sleeping more than usual, vomiting, diarrhea, decreased appetite and irritable.
Member was vaccinated on 1 May 04. He developed hives approximately 10 or 11 May 04. He has been taking benedryl since the time of vaccination.
p/vax pt exp a maculopapular pruritic rash on lower trunk, face & neck;pt was afeb w/no arthralgias, muscle aches or inj site rxn;
The day after getting the Shingrix vaccine the patient's arm got swollen, red, and very painful (she had a hard time moving her arm, the pain was inside her arm). The pain lasted for 3 weeks, the redness and swelling lasted 2 weeks. The patient was seen by her PCP and they indicated that they thought she had an allergic reaction to the vaccine. The patient went to see her PCP two to three days after receiving the vaccine. The doctor gave her diclofenac gel to apply which helped a little. She used the gel for about a week.
freezing cold; shakiness/Like if the body was fighting something; Shivering; This spontaneous case was reported by an other health care professional and describes the occurrence of NASOPHARYNGITIS (freezing cold), TREMOR (shakiness/Like if the body was fighting something) and CHILLS (Shivering) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Heart disorder. Concomitant products included SACUBITRIL, VALSARTAN (ENTRESTO) and CARVEDILOL for Heart disorder.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (freezing cold), TREMOR (shakiness/Like if the body was fighting something) and CHILLS (Shivering). At the time of the report, NASOPHARYNGITIS (freezing cold), TREMOR (shakiness/Like if the body was fighting something) and CHILLS (Shivering) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.   This case was linked to MOD-2022-667345 (Patient Link).
Diarrhea; Arm aching; Chills; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Mar2021 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. On 09Apr2021 at 12:30, the patient experienced diarrhea which started 1 week after receiving first shot, arm aching for 2 days and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm aching was recovered on 11Apr2021, after 2 days and the outcome of the events diarrhea and chills was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician via observant LLC concerning a 21 year old female who was vaccinated with GARDASIL. There was no concomitant medication. In summer 2009 the patient passed out after GARDASIL shot. The patient recovered with sequelae from passed out.  The reporter considered passed out to be an other important medical event.  No further information is available.
Exactly two weeks after my first moderna Vaccine shot I got a rash under the site injection spot.  It's about 3-4 inches wide and about 2 inches in depth.  It is hotter then the rest of my skin.
Had an aura at about 7:30pm on 2/10/2021 about 27 hours after vaccination, lasted about an hour, no headache developed.  Do have history of migraines when around puberty that usually began with an aura...have not have one in about 10 _+ years .No
Client should have received a Pfizer vaccine for this second vaccination but received the Moderna dose instead. No know side effects occurred at the time of injection.
pt recv vax 12JAN96 & devel a fever 102 which persisted for 48hr, adenitis in axilla of injected arm, cellulitis @ inj site, myalgia & malaise;pt is currently recovering;
I had some terrible, terrible dizziness really, really bad; This is a spontaneous report from a contactable consumer (patient). A 91-year-old patient of an unspecified gender received the first dose of bnt162b2 (BNT162B2, lot number/batch and expiry date were not reported), via an unspecified route of administration from an unspecified date to an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history included hearing was not as good. The patient's concomitant medications were not reported. The patient informed of some terrible, terrible dizziness really, really bad on an unspecified date. The outcome of event was unknown.   Information about Batch/Lot number has been requested.
Majority or all of vaccine volume exited between the needle and syringe and did not make it to the patient. Device failure likely due to typhoid syringe geometry.
35 year old female reported going to the emergency room on 10/13/2021 for polyuria and polydipsia and hyperglycemia. Her A1c was 4.9 on 11/2020 and increased to 8.4 on 10/13/2021 and blood sugar of 500. Her blood sugar trended down with treatment with Insulin and normal saline
Developed fatigue/tiredness which has been ongoing up until this time. Also, on 01/09/21 developed redness, swelling and warmth to injection site approximately 4-5 inches around site which lasted 2 days.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Mild, Additional Details: EMT called as precaution. By EMT arrival patient was back to normal and signed off on release to go under her own capacity.
Approximately 4 hours after the vaccine administration, I started getting symptoms that started mild and became severe including: headache, dry cough with chest pressure, dizziness/lightheaded,  joint pain, body aches, fatigue, and chills. At 5:30 pm I started getting a fever, that started at 100.5 then increased to 103.3 by 8:30 pm. I was also nauseous and vomited once.  I was tested the next morning for influenza and COVID and was negative. My fever came back down to 98.8 around 12 pm the next day. Overall, symptoms lasted approximately 30 hours after the vaccine was administered.  I was out of work the following day after the vaccine. Now, 2 days after the vaccine I am just mildly fatigued with a dry cough left.
1. Fever ~101 for 48 hours, dropping to 99.5 next 24 hours 2. Very achy muscles for ~48 hours, slight to moderate achy next 24 hours. 3. Very fatigued 36 hours, gradual improvement for next 32 hours. 4. Painful skin on both arms and hands for ~36 hours. 5. Swollen lower right leg and ankle for 24 hours. 6. Water retention for 12 hours.  Treated self with Tylenol initial 12 hours then Advil afterwards.
Left arm pit swollen and sore; Left arm pit swollen and sore; This is a spontaneous report from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included osteopenia. The patient received other medication within two weeks of vaccination which included Vitamin D (MANUFACTURER UNKNOWN) and a Multi-Vitamin for unknown indication. The patient received vaccine within four weeks prior to the vaccination which included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 17:00 the patient experienced left arm pit swollen and sore. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events left arm pit swollen and sore was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained
About 3" below the injection site 2 days after vaccine had an area about 5" x 3" red and warm to touch. Showed PCP Mon. 10/1/18 (Oct). She wasn't sure if allergic reaction. No temperature. Pain where shot given.
Member reported a large local reaction with possibly tape allergy. 7-8 cm on left arm; 3cm pustule on right pectoralis. Member experienced headache, muscle aches, swollen lymph nodes and left axilla with 3.5 hours of missed work.
Expired Vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was infection control manager.  Concomitant medication of the patient was not reported.  Date the vial was placed in the refrigerator was 21-Sep-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
This spontaneous report as received from registered nurse (R.N.) refers to an unknown number of unidentified patients. On an unknown date the patients were vaccinated with a dose of ZOSTAVAX (Lot # not reported) (dose and route not reported). Concomitant therapy was not reported. It was reported that the ZOSTAVAX administered was improperly stored. The nurse requested when safety follows up with their office to put a statement that there were no adverse effects reported. Additional information has been requested.
7 days after vaccination(1/30), itchiness and redness appeared around vaccination site (right arm).  Some swelling of site was apparent oln 1/31.  Redness continue to expand on 1/31 and 2/1.  Arm is warm to touch Treated with Advil every 4 hours on 1/31 and 2/1.  Also used cold pack once on 1/31.
Patient states she started running low grade fever of 100.3 on 1/14/2021. She treated it with Tylenol. On 1/16/2021, she stated that the redness started at her injection site it measured about 3 inches X 2 inches.  On 1/18/2021 the redness had spread going down her arm. She reached out to Health Provider and they recommended taking benadryl and zyrtec. Today (1/19/2021) she presents with redness to her left arm, measuring 6 inches, by  4 inches. The red areas are warm to touch and swollen. She denies pain, itching, and fever. Recommended to continue taking medications and apply cool compresses to redness.
First vaccine administered- Second vaccine- fever, chills, pain at injection site, temperature 103. 4, malaise, joint pain
WRONG IMMUNIZATION GIVEN GAVE PEDIARIX AND SHOULD HAVE BEEN HEP A
Moderna COVID?19 Vaccine EUA Fever and groggy. Dizzy at times.
Systemic: pt got blurry vision-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: pt stated she was having severe anxiety she got blurry vision and she thought she will pass out so called 911 and upon evaluation by 911 everything vitals were normal she drank water and was just fine she developed anxiety to needles and vaccines and she might be dehydrated but not sure . she left pharmacy with no diffuclties and 911 said she is just fine and can go home
Pt c/o fatigue, chills, malaise, redness, swelling & pain at injection site on (L) arm (deltoid); c/o swollen lymph node in (L) axilla; also c/o nausea, HA.
Had my first shot on 03/26/21 at pharmacy and the second on 04/16/21 LOT#ER8731 at pharmacy. With the first shot I was hot but that symptom went away in the 15 minute wait time, I had acetaminophen and an allergy medication before coming to the pharmacy.  With the second shot I had neither before arriving but took them as soon as I arrived home. I work for a bus company and have been driving the same sets of children since January 2021, on last week approx. Wednesday I started to sweat but put it down to the changing weather. Saturday, April 23,2021 I was sweating profusely and thought to drink a lot of water. By Sunday I was experiencing a lot loose diarrhea and thought it would be better to not attend work on Monday, April 26, 2021. I should also mention that the previous week at work my stomach was bothering  me and could barely make it to the restroom. The end result is that from Saturday through today Tuesday I have had headaches in the weirdest  places the back of my head where the spine meets and in the top of my head. The middle of my forehead and the lower portions of my temporal lobe. I tended to lay down because I would get dizzy and the nausea was getting to be a bit much. No vomiting but I did purchase some Citrus Twist ( similar to Sprite) and that calmed down the nausea. Upon going to the Clinic today I was given a COVID Test and the Clinician suggested a follow up with my Primary, She also suggested that above might be Gastro in  nature. Made an appointment and am reporting to VAERS about the possible Adverse Recation.
Information has been received from a nurse concerning a 27 year old female (inappropriate age) who on 15-MAR-2007 was vaccinated with HPV. On 15-MAR-2007, the patient experienced burning in her arm near the injection site as well as burning in her throat after receiving HPV. The patient sought unspecified medical attention. On 15-MAR-2007, the patient recovered from burning in her arm near the injection site and burning in her throat. Additional information has been requested.
Information has been received from a physician via Pfizer (MFC#2016286137) on 10-JUN-2016 referring to unknown number of patients of unknown age and gender. Information about concurrent condition, medical history and concomitant medication was not provided. On unknown dates the patients were vaccinated with doses of PNEUMOVAX 23 (dose, dose#, lot# and route unknown). On unknown dates the patients experienced reaction to PNEUMOVAX 23 such as Guillain's Barre syndrome and hypersensitivity, et al. The outcome of the events was unknown. Upon internal review, the event Guillain's Barre syndrome was considered to be medically significant. Additional information has been requested.
Arm soreness. Began within 20 minutes after injection, continued for 3 days. Treated with ibuprofen, which helped reduce soreness.
27OCT10-Left shoulder pain-unable to get full ROM, neck & back pain.  Right 3rd digit joint pain unable to close fist. Right 2nd digit numb and nausea. 31Oct10-severe heel pain causing difficulty walking, bilateral knee pain, above s/s still present. 8Nov10-right 2nd digit numb, all other s/s gone.
I have been keeping track of the covid vaccines in the clinic. LPN is a new hire to the clinic and was made aware of the covid vaccines and location for the covid book during her three-day clinic training.  On 07/08/2022 I was out of the clinic due to a death in family and did not return until 07/15/2022. Upon my return I was notified that covid vaccines had been administered. There were two open vials (one Pfizer vaccine and one Moderna) in the refrigerator that I discarded on the morning of 07/15/2022 when performing vaccine daily inventory count. (There were no medication errors with Moderna vaccine, only Pfizer) The Pfizer count on the daily inventory log prior to me leaving on 07/07/2022 was 39 vials.  The Pfizer count on the covid vaccine daily inventory log on 07/15/2022 was 39. There was one Pfizer vaccine given on 07/08/2022 administered to MRN# 13407855 by NP. There was one Pfizer vaccine administered on 07/12/2022 to MRN# 13150437 by RN. One Pfizer administered on 07/14/2022 to MRN # 13825361 by LPN.   I checked the dates on the opened vials to make sure that what I was seeing on the daily log was the same as what was on the vial,  and the date on the Pfizer vial was 07/08/2022.  I spoke with LPN on 07/18/2022 who states she was not in clinic on 07/08/2022 and she administered one Pfizer vaccine on 07/14/2022. When asked if she opened a new vial of Pfizer vaccine on 07/14/2022 or if she gave from the previously open Pfizer vial, she stated that she did not open a new Pfizer vial, she used the Pfizer vial that was previously opened.   I reported the incident to Dr. on 07/15/2022 and Clinic Manager on 07/27/2022.   At this time, no one is administering covid vaccines other than myself and I continue to retrain others in the clinic on administration of covid vaccines and storage and safety of vaccines.
patient's girlfriend called pharmacy at 5:25 pm, she stated that patient and herself (she also received vaccination same day) was experiencing numbness in face and face felt like pins and needles. I told girlfriend for her and patient to both take a Benadryl and that I would contact our clinical department to seek further advice.  at 5:27 pm I called clinical department; they told me symptoms could possibly be anaphylaxis or affecting nerves. at 5:35 pm I called girlfriend back, instructed for her and patient to go to emergency room due to the possible side effects explained to me by our clinical  department. Girlfriend said the she and patient are going to "wait it out". I told girlfriend I would follow up with her and patient in an hour.
Client was administered vaccine approximately 11:15 am. 11:45 return to clinic "itching" head, cheeks, reddened. Hives present on cheeks, axillary area and neck. Child taken to ER. Mother stated child receive Benadryl IM. Return to clinic 3:30pm. No hive present. Telephone call to parent 8/2/07. Child without any adverse effects.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 22Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes T1" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Indication=Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid, treatment start date 24Oct2022, treatment stop date= 29Oct2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Tested positive for COVID-19 I experienced mild symptoms. Runny nose, cough, head congestion, extreme fatigue for 6 days.